financetom
Business
financetom
/
Business
/
Chesapeake Energy misses quarterly profit estimates as natgas prices remain low
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Chesapeake Energy misses quarterly profit estimates as natgas prices remain low
Apr 30, 2024 1:42 PM

(Reuters) - Natural gas producer Chesapeake Energy Corp missed Wall Street estimates for first-quarter profit on Tuesday as persistently low natural gas prices weighed down on the company's top-line results.

The company's adjusted profit was 56 cents per share for the three months ended March 31, compared with analysts' average estimate of 60 cents per share, according to LSEG data.

Natural gas prices had dropped 20.4% in the first quarter compared with the year-ago quarter, as high inventory combined with lackluster demand resulted in producers such as Chesapeake curtailing gas production.

The company said that it plans to drop an additional rig in the Marcellus around mid-year.

Revenue from its natural gas, oil and natural gas liquids (NGL) unit dropped to $589 million, compared with $1.45 billion in the year-ago quarter.

Chesapeake, which is on the cusp of becoming the biggest natural gas producer pending its acquisition of Southwestern Energy, reported quarterly net production of 3.20 billions of cubic feet equivalent per day (bcfepd), utilizing an average of nine rigs.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Copyright 2023-2025 - www.financetom.com All Rights Reserved